(株)医学生物学研究所の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証JQS医薬品4557/E00978-
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2019/10/18日証協無担保0株0%13,800株-22.47%48,900株+4.97%
2019/10/18日証協有担保179,221株+31.54%27,179株+31.94%97,621株+34.84%
2019/10/11日証協無担保0株0%17,800株+2.3%46,583株+0.59%
2019/10/11日証協有担保136,245株+9.66%20,600株+4.04%72,400株+39.25%
2019/10/04日証協無担保0株0%17,400株+31.82%46,312株+78.49%
2019/10/04日証協有担保124,239株+1.05%19,800株-9.17%51,994株+10.16%
2019/09/27日証協無担保0株-100%13,200株+1.54%25,946株-5.05%
2019/09/27日証協有担保122,945株+3.54%21,800株-3.11%47,200株+5.59%
2019/09/20日証協無担保1,900株0%13,000株0%27,327株+0.78%
2019/09/20日証協有担保118,745株-2.32%22,500株0%44,700株-13.4%
2019/09/13日証協無担保0株0%13,000株+0.78%27,116株-34.68%
2019/09/13日証協有担保121,561株+23.98%22,500株0%51,616株+61.81%
2019/09/06日証協無担保0株0%12,900株+148.08%41,511株+4.14%
2019/09/06日証協有担保98,045株-11.39%22,500株-23.47%31,900株-12.36%
2019/08/30日証協無担保0株0%5,200株+100%39,862株+38.54%
2019/08/30日証協有担保110,645株-15.7%29,400株+31.25%36,400株-3.96%
2019/08/23日証協無担保0株0%2,600株+44.44%28,773株-12.17%
2019/08/23日証協有担保131,245株-14.3%22,400株-3.86%37,900株-25.98%
2019/08/16日証協無担保0株0%1,800株0%32,761株+44.63%
2019/08/16日証協有担保153,145株+2%23,300株+3.1%51,200株+5.79%
2019/08/09日証協無担保0株0%1,800株0%22,651株+8.11%
2019/08/09日証協有担保150,145株+26.75%22,600株+111.21%48,400株+18.05%
2019/08/02日証協無担保0株0%1,800株+12.5%20,952株+5.56%
2019/08/02日証協有担保118,461株+4.87%10,700株+109.8%41,000株-5.35%
2019/07/26日証協無担保0株0%1,600株0%19,849株-2.93%
2019/07/26日証協有担保112,961株-6.91%5,100株0%43,316株-7.25%
2019/07/19日証協無担保0株0%1,600株0%20,449株+0.03%
2019/07/19日証協有担保121,345株+1.51%5,100株0%46,700株+3.32%
2019/07/12日証協無担保0株0%1,600株0%20,443株+2.53%
2019/07/12日証協有担保119,545株-19.63%5,100株-25%45,200株-37.05%
2019/07/05日証協無担保0株0%1,600株0%19,938株+2.52%
2019/07/05日証協有担保148,745株+1.5%6,800株-1.45%71,800株+1.56%
2019/06/28日証協無担保0株0%1,600株-92.25%19,448株+0.95%
2019/06/28日証協有担保146,545株-5.6%6,900株-65.15%70,700株+65.96%
2019/06/21日証協無担保0株0%20,655株+1190.94%19,265株-3.01%
2019/06/21日証協有担保155,245株+4.72%19,800株+83.33%42,600株-24.6%
2019/06/14日証協無担保0株0%1,600株+6.67%19,863株-11.11%
2019/06/14日証協有担保148,245株+24.32%10,800株+1700%56,500株+70.18%

※株式分割は考慮していませんのでご注意ください。

Page Top